Ashley Xu
Analyst
Piper Sandler
Equibles does not estimate personal net worth.
About Ashley Xu
Ashley Xu is recorded as Analyst at Piper Sandler. Ashley Xu has spoken on 3 earnings calls and 1 other investor event across 4 companies, most recently for Rigel Pharmaceuticals Inc on May 12, 2026. Those appearances were for Rigel Pharmaceuticals Inc (RIGL), Alx Oncology Holdings Inc (ALXO), Ardelyx, Inc. (ARDX) and Akebia Therapeutics, Inc. (AKBA). The companies whose calls Ashley Xu spoke on are classified in the Healthcare sector.
Ashley Xu on recent calls
“I was just curious to get your thoughts and also hear Dr. Hamilton chime in. With the label requiring an FDA-authorized test for ESR1 You know, what's the strategy for ensuring broad access, you know, to diagnostic testing, you know, to facilitate rapid patient identification and uptake?”
“So just curious to learn what's the latest on the companion diagnostic development. I know you guys have talked about this on previous earnings calls. So just looking for some updated thoughts there.”
“You talked about it in your prepared remarks, but could you talk a little more about the Absarilla pediatric trials and just the workings of the potential six months of additional patent life and how meaningful those additional six months could be for Absarilla?”
“Just one question from us, because you guys did a great job of answering our other questions, but just on the R&D day on April 2nd, when you're discussing your pipeline, can you help frame some expectations for investors?”
Affiliation history
-
Piper Sandler
Analyst
Transcript header (unverified)
Current
Company network
Ardelyx, Inc.
ARDX
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-04-30
View calls and events
Drug Manufacturers - Specialty & Generic · Healthcare
1 appearance
Latest appearance 2026-02-26
View calls and events